Relax Pharmacy Regulations to Help with COVID-19 Testing and Treatment

7 Pages Posted: 31 Mar 2020

See all articles by James Broughel

James Broughel

George Mason University - Mercatus Center

Yuliya Yatsyshina

Independent

Date Written: March 27, 2020

Abstract

One of the most urgent challenges facing policymakers managing the current COVID-19 public health crisis is how to ramp up diagnostic testing on a mass scale. Companies such as Walgreens, CVS, and Target have already started working with the federal government, as their locations are well-suited to become testing sites. As a result, pharmacies and pharmacists themselves are likely to become instrumental in testing for COVID-19 in the coming weeks and months. However, certain regulatory restrictions on pharmacists should be relaxed so that they can practice to the full extent of their training and abilities.

Keywords: pharmacy; regulation; pharmacist; healthcare; coronavirus; coronavirus pandemic; COVID-19; public health; economics

JEL Classification: H75, I00, I13, I18

Suggested Citation

Broughel, James and Yatsyshina, Yuliya, Relax Pharmacy Regulations to Help with COVID-19 Testing and Treatment (March 27, 2020). Mercatus Center Research Paper Series, Special Edition Policy Brief (2020), Available at SSRN: https://ssrn.com/abstract=3564463 or http://dx.doi.org/10.2139/ssrn.3564463

James Broughel (Contact Author)

George Mason University - Mercatus Center ( email )

3434 Washington Blvd., 4th Floor
Arlington, VA 22201
United States

HOME PAGE: http://www.mercatus.org/scholars/james-broughel

Yuliya Yatsyshina

Independent

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
128
Abstract Views
1,479
rank
262,268
PlumX Metrics